A world-leading international trial into the immune boosting benefits of the tuberculosis vaccine, BCG, has found it does not protect healthcare workers against COVID-19.

The Key Asks outline the top priorities the TB community is requesting member states to include in the Political Declaration which is expected to be endorsed by Heads of State during the UN High-Level Meeting on TB in September.

Access to TB drug bedaquiline, a backbone medicine for drug-resistant TB treatment regimens, remains out of reach for too many.

Tuberculosis, a bacterial lung infection, is one of the leading causes of death worldwide and is becoming increasingly resistant to antibacterial treatments. 

Tuberculosis (TB) is one of the deadliest infectious diseases worldwide that is spread in the air like the common cold. TB is caused by the bacterium Mycobacterium tuberculosis (Mtb) and was responsible for approximately 1.6 million deaths in 2021. Mtb will usually attack the lungs but can attack any part of the body. Drug resistant TB strains are spreading and present a major concern. New work and a paper by a team of scientists from Manchester, Cambridge and Huddersfield Universities using a structure-guided approach, combined with biophysical characterization obtained a series of compounds with activity against clinically relevant drug-resistant isolates. These will support further development of much-needed additional treatment options against Mtb.

21 April 2023, Geneva | The World Health Organization (WHO) welcomes the new decree by the President of Brazil, His Excellency Luiz Inácio Lula da Silva on the establishment of an Interministerial Committee for the Elimination of Tuberculosis and other Socially Determined Diseases (CIEDS).

Artificial intelligence (AI) software can detect tuberculosis (TB) from chest x-rays at an accuracy level comparable to, or better than, that of the radiologists tested, new research indicates.

The Standard sets benchmarks to achieve universal access to WHO-recommended rapid diagnostics, increase bacteriologically confirmed TB and drug resistance detection, and reduce the time to diagnosis.

TAG and IMPAACT4TB project partners release several materials to explain how the identification of nitrosamines in rifampicin and rifapentine may affect the safety and supply of TB medicines, and what this may mean for TB programs and patients.

The International Union Against Tuberculosis and Lung Disease (The Union) released its quarterly training and education newsletter (January - March 2023), sharing the latest news and updates from The Union courses.